Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidar Sharafi

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 30, 2023
Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMAHamzah Bakouni, Heidar Sharafi, Sarah Drouin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 3, 2019
Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison settingHeidar Sharafi, Hossein Poustchi, Fatemeh Azimian, et al.
Drug and Alcohol Dependence|November 18, 2023
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trialsHamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
Harm Reduction Journal|April 8, 2025
Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in IranMehrdad Khezri, Fatemeh Tavakoli, Soheil Mehmandoost, et al.
Substance Abuse Treatment, Prevention, and Policy|November 29, 2023
Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam studySoheil Mehmandoost, Ali Mirzazadeh, Mohammad Karamouzian, et al.
Harm Reduction Journal|October 21, 2020
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals eraSanam Hariri, Heidar Sharafi, Mahdi Sheikh, et al.
The International Journal on Drug Policy|October 27, 2019
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in IranGhobad Moradi, Behzad Hajarizadeh, Khaled Rahmani, et al.
Addiction (Abingdon, England)|October 26, 2023
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trialsHeidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Drug and Alcohol Dependence|January 9, 2023
Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in IranMehrdad Khezri, Ali Mirzazadeh, Mostafa Shokoohi, et al.
The International Journal on Drug Policy|January 25, 2022
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam studyAli Mirzazadeh, Samira Hosseini-Hooshyar, Armita Shahesmaeili, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 30, 2023
Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances non opioïdes dans le trouble lié à l'usage d'opioïdes de type sur ordonnance : analyses secondaires de l'étude OPTIMAHamzah Bakouni, Heidar Sharafi, Sarah Drouin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 3, 2019
Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison settingHeidar Sharafi, Hossein Poustchi, Fatemeh Azimian, et al.
Drug and Alcohol Dependence|November 18, 2023
Bupropion for treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of placebo-controlled randomized clinical trialsHamzah Bakouni, Heidar Sharafi, Arash Bahremand, et al.
Harm Reduction Journal|April 8, 2025
Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in IranMehrdad Khezri, Fatemeh Tavakoli, Soheil Mehmandoost, et al.
Substance Abuse Treatment, Prevention, and Policy|November 29, 2023
Injection cessation and relapse to injection and the associated factors among people who inject drugs in Iran: The Rostam studySoheil Mehmandoost, Ali Mirzazadeh, Mohammad Karamouzian, et al.
Harm Reduction Journal|October 21, 2020
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals eraSanam Hariri, Heidar Sharafi, Mahdi Sheikh, et al.
The International Journal on Drug Policy|October 27, 2019
Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in IranGhobad Moradi, Behzad Hajarizadeh, Khaled Rahmani, et al.
Addiction (Abingdon, England)|October 26, 2023
Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trialsHeidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Drug and Alcohol Dependence|January 9, 2023
Hepatitis C virus prevalence, determinants, and cascade of care among people who inject drugs in IranMehrdad Khezri, Ali Mirzazadeh, Mostafa Shokoohi, et al.
The International Journal on Drug Policy|January 25, 2022
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam studyAli Mirzazadeh, Samira Hosseini-Hooshyar, Armita Shahesmaeili, et al.
Pageof 7